FHIR IG analytics| Package | hl7.eu.fhir.gh |
| Resource Type | MedicinalProductDefinition |
| Id | MedicinalProductDefinition-medprodherceptin150.json |
| FHIR Version | R5 |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: MedicinalProductDefinition medprodherceptin150
Profile: MedicinalProductDefinition (ePI)
identifier: http://iyaku.info/medicine/4291447D2024
type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: Herceptin (trastazumab) 150 mg
type: Full name
part
part: Herceptin
type: Invented name part
part
part: trastazumab
type: Scientific name part
part
part: 150 mg
type: Strength part
part
part: Intravenous infusion
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language Japan Japan Japanese (Region=Japan)
{
"resourceType": "MedicinalProductDefinition",
"id": "medprodherceptin150",
"meta": {
"profile": [
"http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi"
]
},
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"identifier": [
{
"system": "http://iyaku.info/medicine",
"value": "4291447D2024"
}
],
"type": {
"coding": [
{
"system": "http://hl7.org/fhir/medicinal-product-type",
"code": "MedicinalProduct",
"display": "Medicinal Product"
}
]
},
"domain": {
"coding": [
{
"system": "http://hl7.org/fhir/medicinal-product-domain",
"code": "Human",
"display": "Human use"
}
]
},
"status": {
"coding": [
{
"system": "http://hl7.org/fhir/publication-status",
"code": "active",
"display": "active"
}
]
},
"legalStatusOfSupply": {
"coding": [
{
"system": "https://spor.ema.europa.eu/rmswi",
"code": "100000072084",
"display": "Medicinal product subject to medical prescription"
}
]
},
"name": [
{
"productName": "Herceptin (trastazumab) 150 mg",
"type": {
"coding": [
{
"system": "https://spor.ema.europa.eu/lists/220000000000",
"code": "220000000001"
}
],
"text": "Full name"
},
"part": [
{
"part": "Herceptin",
"type": {
"coding": [
{
"system": "https://spor.ema.europa.eu/lists/220000000000",
"code": "220000000002"
}
],
"text": "Invented name part"
}
},
{
"part": "trastazumab",
"type": {
"coding": [
{
"system": "https://spor.ema.europa.eu/lists/220000000000",
"code": "220000000003"
}
],
"text": "Scientific name part"
}
},
{
"part": "150 mg",
"type": {
"coding": [
{
"system": "https://spor.ema.europa.eu/lists/220000000000",
"code": "220000000004"
}
],
"text": "Strength part"
}
},
{
"part": "Intravenous infusion",
"type": {
"coding": [
{
"system": "https://spor.ema.europa.eu/lists/220000000000",
"code": "100000075213"
}
],
"text": "Pharmaceutical dose form part"
}
}
],
"usage": [
{
"country": {
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "JP"
}
]
},
"jurisdiction": {
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "JP"
}
]
},
"language": {
"coding": [
{
"system": "urn:ietf:bcp:47",
"code": "ja-JP"
}
]
}
}
]
}
]
}